Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Nov 15, 2024; 16(11): 4436-4455
Published online Nov 15, 2024. doi: 10.4251/wjgo.v16.i11.4436
Published online Nov 15, 2024. doi: 10.4251/wjgo.v16.i11.4436
Cluster | Score | Nodes | Edges | Node IDs |
1 | 3.333 | 4 | 5 | GRIA2, GRIA4, TSPAN7, PRKCG |
2 | 3.333 | 4 | 5 | NOD2, TNFAIP3, BIRC3, TLR4 |
3 | 3 | 3 | 3 | WNT10B, LRP5, WNT3A |
4 | 3 | 3 | 3 | HIST1H1E, HIST1H4E, HIST1H3J |
5 | 3 | 3 | 3 | HBB, HBA2, HBA1 |
6 | 3 | 3 | 3 | GUCY1B3, GUCY1A3, PRKG1 |
7 | 3 | 3 | 3 | HLA-DRA, GNAO1, HLA-DRB1 |
8 | 3 | 3 | 3 | TPO, DDC, IL4I1 |
9 | 3 | 3 | 3 | PER3, CSNK1E, PER1 |
10 | 3 | 3 | 3 | MMP13, COL9A1, COL9A2 |
11 | 3 | 3 | 3 | SPON2, ADAMTS9, SEMA5A |
- Citation: Li SL, Wang PY, Jia YP, Zhang ZX, He HY, Chen PY, Liu X, Liu B, Lu L, Fu WH. BIRC3 induces the phosphoinositide 3-kinase-Akt pathway activation to promote trastuzumab resistance in human epidermal growth factor receptor 2-positive gastric cancer. World J Gastrointest Oncol 2024; 16(11): 4436-4455
- URL: https://www.wjgnet.com/1948-5204/full/v16/i11/4436.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i11.4436